Clinical, pathological and treatment factors associated with the survival of patients with pulmonary sarcomatoid carcinoma.

ABSTRACT: Pulmonary sarcomatoid carcinoma (PSC) is a group of five rare non-small cell lung cancer subtypes. In the present study, the clinical characteristics and outcomes of patients with PSC registered in the Surveillance, Epidemiology and End Results (SEER) database were investigated. For this purpose, data for patients with PSC (n=1,723) who received their initial diagnosis between 1988 and 2016 were collected from the SEER database. Survival analysis was performed using the Kaplan-Meier curves and the log-rank test. Subsequently, multivariate analyses with the Cox proportional hazards model were used to identify significant independent predictors. A nomogram model was established to predict survival performance using the concordance index (C-index). From the total cohort, patients with pulmona

SUBMITTER: Liang X 

PROVIDER: S-EPMC7202303 | biostudies-literature | 2020 Jun

REPOSITORIES: biostudies-literature